Between Aug News Today

1. Clinically relevant bleeding was significantly lower with ticagrelor monotherapy than in the ticagrelor plus aspirin group. 2. Major cardiovascular and cerebrovascular events were comparable in both groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Dual antiplatelet therapy (DAPT) is the current standard of care for acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI).

1. Target-vessel failure was significantly lower in the ultrasound-guided group than the angiography-guided group. 2. There was no significant difference between groups concerning stent thrombosis. Evidence Rating Level: 1 (Excellent) Study Rundown: Angiography-guided percutaneous coronary intervention (PCI) is the current standard of care for patients with coronary artery stenosis, although this is associated with complications.

1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable concentrations of antibodies persisted at the 8.5-year mark in Qindong. Evidence Rating Level: 1 (Excellent) Study Rundown: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis worldwide. Currently, two recombinant HEV vaccines exist; however, little is known

1. Aflibercept 8 mg was non-inferior to 2 mg for best-corrected visual acuity at 48 weeks. 2. Ocular adverse events were comparable across treatment groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Neovascular age-related macular degeneration (nAMD) is a major cause of vision loss worldwide. Anti-vascular endothelial growth factors, such as aflibercept, may improve treatment

1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable concentrations of antibodies persisted at the 8.5-year mark in Qindong. Evidence Rating Level: 1 (Excellent) Study Rundown: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis worldwide. Currently, two recombinant HEV vaccines exist; however, little is known

Surat: A 32-year-old Dindoli resident lost Rs 1.

1. Absence of moderate or severe headache 24 hours following administration of treatment drug was significantly greater among patients with migraine attacks that were treated with ubrogepant during the prodrome phase. 2. Adverse events were slightly more frequent in the ubrogepant group versus placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Ubrogepant, a calcitonin gene-related

1. Patients in the primaquine group reported a significant reduction in parasitemia risk at day 63 compared to those in the standard care group. 2. The majority of adverse events were mild-to-moderate with no treatment-related deaths. Evidence Rating Level: 1 (Excellent) Study Rundown: In areas where Plasmodium vivax and Plasmodium falciparum coexist, there exists an

1. All-cause mortality after 5 years was similar for patients in the adaptive and conventional CRT groups. 2. System-related adverse events exhibited no significant disparity between groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Cardiac resynchronization therapy (CRT) is the standard of care among patients with decompensated heart failure and left bundle branch block. However,

1. Sleep restriction therapy was superior to sleep hygiene for the management of chronic insomnia. 2. There were no treatment-related adverse events. Evidence Rating Level: 1 (Excellent) Study Rundown: Insomnia is a chronic disorder affecting 10% of people worldwide. Although cognitive behavioural therapy (CBT) remains the primary treatment for insomnia, access to this is scarce.